logo

For the Inventor, By the Inventor

Fukuoka, Japan

Noriyuki Sueyoshi

This inventor holds 3 USPTO granted patents. Top assignees: Takara Bio Inc., Takara Shuzo Co., Inc.. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Sueyoshi. Retrieved from https://idiyas.com/inventor/noriyuki-sueyoshi-8l9i2ug7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 33.3

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Fukuoka, JP (2002 - 2004)
  • Koga, JP (2006)

Company Filing History:

goldMedal2 out of 150 
 
Takara Bio Inc.
 patents
silverMedal1 out of 190 
 
Takara Shuzo Co., Inc.
 patents

Years Active: 2002-2006

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7101699 - Sphingolipid ceramide deacylase gene (2006-09-05),
2. 6821761 - Sphingolipid ceramide N-deacylase, methods for producing sphingolipids and sphingolipid derivatives, and sphingolipid ceramide N-deacylase gene (2004-11-23),
3. 6428999 - Sphingolipid ceramide N-deacylase, methods for producing sphingolipids and sphingolipid derivatives, and spingolipid ceramide N-deacylase gene (2002-08-06),

Title: Noriyuki Sueyoshi: Innovator in Sphingolipid Technology

Introduction

Noriyuki Sueyoshi is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of sphingolipid technology, holding a total of 3 patents. His work focuses on the engineering of sphingolipids and their applications in treating various diseases.

Latest Patents

Sueyoshi's latest patents include innovations related to sphingolipid ceramide deacylase genes and polypeptides. These inventions encompass a range of components, such as a nucleic acid encoding the polypeptide, a recombinant DNA, and methods for detecting the nucleic acid and polypeptide. His inventions aim to facilitate the engineering of sphingolipids and provide treatments for diseases affecting the nervous system, leukemia, and wounds. Additionally, he has developed methods for producing sphingolipids and sphingolipid derivatives, which are valuable in medicine and cell engineering.

Career Highlights

Throughout his career, Sueyoshi has worked with notable companies, including Takara Bio Inc. and Takara Shuzo Co., Inc. His expertise in sphingolipid technology has positioned him as a key figure in the field, contributing to advancements that have the potential to impact medical treatments significantly.

Collaborations

Sueyoshi has collaborated with esteemed colleagues such as Makoto Ito and Susumu Mitsutake. These partnerships have further enhanced his research and development efforts in sphingolipid technology.

Conclusion

Noriyuki Sueyoshi's innovative work in sphingolipid technology and his contributions to medical science highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing the field and improving treatment options for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…